Related Experiment Video
Updated: Jul 29, 2025
05:56
Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
925
Sociodemographic Disparities in Postoperative Nausea and Vomiting
Donaldson C Lee1, Thomas R Vetter2, Jeffrey B Dobyns3
1From the Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Anesthesia and Analgesia
|May 19, 2023
Summary
Disparities in postoperative nausea and vomiting (PONV) prophylaxis exist. Protocol adherence impacts PONV incidence, highlighting the need for equitable care in anesthesia quality.
Area of Science:
- Anesthesiology
- Health Services Research
- Health Equity
Background:
- Postoperative nausea and vomiting (PONV) prophylaxis is a critical measure of anesthesia care quality.
- PONV disproportionately affects disadvantaged patient populations.
- Sociodemographic factors may influence PONV incidence and prophylaxis adherence.
Purpose of the Study:
- To investigate the relationship between sociodemographic factors and PONV incidence.
- To examine clinician adherence to a PONV prophylaxis protocol.
- To identify potential disparities in PONV prophylaxis and outcomes.
Main Methods:
- Retrospective analysis of 8384 patients undergoing procedures with a PONV prophylaxis protocol (2015-2017).
- Collection of sociodemographic, PONV risk, and protocol adherence data.
- Multivariable logistic regression to assess associations between patient characteristics, PONV incidence, and protocol adherence.
Main Results:
- Black patients had a lower risk of PONV (aOR, 0.83) and less likely to experience PONV when protocol was followed (aOR, 0.81).
- Medicaid patients were less likely to experience PONV with protocol adherence (aOR, 0.72).
- Hispanic patients had higher PONV risk (aOR, 2.96) when protocol was followed for high-risk cases. Protocol adherence was lower for Black patients with moderate/high risk.
Conclusions:
- Significant racial and sociodemographic disparities exist in PONV incidence and prophylaxis protocol adherence.
- Addressing these disparities is crucial for improving perioperative care quality.
- Awareness and targeted interventions can mitigate inequities in PONV management.
Related Concept Videos
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
259
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
259
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
212
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
212
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
360
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
360
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
329
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
329
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
131
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
131
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
355
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
355